About this trial
This is a retrospective-prospective study conducted at Zhongshan Hospital, Fudan University, to explore portal vein thrombosis (PVT) in patients with cirrhosis and gastroesophageal varices (GEV). It aimed to provide insights into the diagnosis, follow-up, and factors influencing PVT recanalization, to help patients, families, and healthcare providers understand the disease and related clinical management.
Eligibility criteria
Qualifiers
diagnosed as cirrhosis and confirmed gastroesophageal varices by endoscopy;
all patients were diagnosed as PVT by CTA at admission.
Disqualifiers
patients with hepatocellular carcinoma;
patients with extrahepatic malignancies;
history of liver transplantation or TIPS;
lack of information regarding anticoagulation therapy;
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
1Sponsors and collaborators
Shanghai Zhongshan Hospital
Lead sponsor